It has been found that various resistant cancer cells (like Breast cancer etc.)have mutated CYP genes which reduces its drug-activating efficacy and leads to the breakdown or excretion of drugs without affecting cancer cells [299, 304]. The gene discussed is PPIG; the disease is cancer.